Active Fine Chemicals Limited (DSE:ACTIVEFINE)

Market Cap	2.33B
Revenue (ttm)	1.35B
Net Income (ttm)	-4.54M
Shares Out	239.94M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,493
Average Volume	438,932
Open	9.70
Previous Close	9.60
Day's Range	9.50 - 9.80
52-Week Range	7.50 - 16.80
Beta	0.10
RSI	53.81
Earnings Date	Dec 5, 2024

About Active Fine Chemicals

Active Fine Chemicals Limited produces and sells bulk drugs/active pharmaceutical ingredients (APIs) and various laboratory reagents in Bangladesh. The company’s APIs include azithromycin dihydrate, erythromycin ethyl succinate, and erythromycin stearate for macrolide-antibiotics; esomeprazole magnesium trihydrates and pellets for anti-ulcerant; fluconazoles for anti-fungal; atorvastatin and rosuvastatin calcium for lipid-lowering; cetirizine and fexofenadine hydrochlorides, desloratadines, and ebastine for anti-histamine; and ciprofloxacin hyd...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2004
• Employees: 92
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ACTIVEFINE

Financial Performance

In 2022, Active Fine Chemicals's revenue was 1.67 billion, a decrease of -8.21% compared to the previous year's 1.82 billion. Earnings were 25.91 million, a decrease of -32.31%.